PureTech Health: Notice of Results
April 13 2023 - 1:00AM
Business Wire
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the
"Company") plans to publish its annual report and financial results
on Friday, April 28, 2023, at 2:00 AM EDT/ 7:00 AM BST. The report
will include the Company’s financial results for the year ended
December 31, 2022, and its cash balance for the first quarter ended
March 31, 2023. PureTech also plans to provide an overview of
progress across its Wholly Owned Pipeline and Founded Entities in
addition to the Company’s approach to environmental, social and
governance (ESG) practices, along with other business and strategy
progress and updates.
A presentation and conference call to discuss the results will
take place at 9:00 AM EDT / 2:00 PM BST on the day of publication,
and a webcast of the presentation will be available on the
Company's website at
https://investors.puretechhealth.com/events-presentations.
About PureTech PureTech is a biotherapeutics company
dedicated to changing the treatment paradigm for devastating
diseases. The Company has created a broad and deep pipeline through
the expertise of its experienced research and development team and
its extensive network of scientists, clinicians and industry
leaders. This pipeline, which is being advanced both internally and
through PureTech's Founded Entities, is comprised of 26
therapeutics and therapeutic candidates, including two (Plenity®
and EndeavorRx®) that have received both U.S. FDA clearance and
European marketing authorization and a third (KarXT) that will soon
be filed for FDA approval, as of the most recent update by the
Company. All of the underlying programs and platforms that resulted
in this pipeline of therapeutic candidates were initially
identified or discovered and then advanced by the PureTech team
through key validation points based on its unique insights and
technology platforms.
For more information, visit www.puretechhealth.com or connect
with us on Twitter @puretechh.
Cautionary Note Regarding Forward-Looking Statements This
press release contains statements that are or may be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this press release that do not relate to matters of historical
fact should be considered forward-looking statements, including
without limitation those statements that relate to the company's
future prospects, developments, and strategies. The forward-looking
statements are based on current expectations and are subject to
known and unknown risks, uncertainties and other important factors
that could cause actual results, performance and achievements to
differ materially from current expectations, including, but not
limited to, those risks, uncertainties and other important factors
described under the caption "Risk Factors" in our Annual Report on
Form 20-F for the year ended December 31, 2021, filed with the SEC
and in our other regulatory filings. These forward-looking
statements are based on assumptions regarding the present and
future business strategies of the Company and the environment in
which it will operate in the future. Each forward-looking statement
speaks only as at the date of this press release. Except as
required by law and regulatory requirements, we disclaim any
obligation to update or revise these forward-looking statements,
whether as a result of new information, future events or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230412005780/en/
PureTech Public Relations
publicrelations@puretechhealth.com
Investor Relations IR@puretechhealth.com
EU Media Ben Atwell, Rob Winder +44 (0) 20 3727 1000
ben.atwell@FTIconsulting.com
U.S. Media Nichole Sarkis +1 774 278 8273
nichole@tenbridgecommunications.com
PureTech Health (NASDAQ:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
PureTech Health (NASDAQ:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024